Re-challenge of Anti-EGFR for Patients With RAS/BRAF Wild-type Metastatic CRC

ABSTRACT: The aim of the trial is to study the efficacy and safety of Cetuximab re-challenge for Chinese Patients with RAS/BRAF wild-type Metastatic Colorectal Cancer.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2326638 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR